StockData
HeartSciences Inc. logo

HeartSciences Inc. (HSCS) stock

HSCSNasdaqFinance ServicesFiscal year ends April 30Also trades as HSCSW
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 3/30
$2.06−0.02 (-0.96%)

Close on Nov 17, 2026Market cap $9.89MP/E –Yield 0.00%

HeartSciences r&d expenses

Research and development expenses are spending on new products and technology.

HeartSciences's R&D Expenses for the twelve months ending Jul 31, 2026 was $2.75M, down 33.9% year over year. For fiscal 2026 it was $2.84M, down 35.3% from the year before. The highest annual figure on record is $4.39M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2026Apr 30, 2026$2.84M-35.3%
FY2025Apr 30, 2025$4.39M+52.4%
FY2024Apr 30, 2024$2.88M+17.0%
FY2023Apr 30, 2023$2.46M-18.0%
FY2022Apr 30, 2022$3.00M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jul 31, 2026$906.63K-9.1%
Q4 FY2026CQ1 2026Apr 30, 2026$476.21K-48.7%
Q3 FY2026CQ4 2025Jan 31, 2026$638.58K-38.2%
Q2 FY2026CQ3 2025Oct 31, 2025$727.03K-39.4%
Q1 FY2026CQ2 2025Jul 31, 2025$997.21K-18.6%
Q4 FY2025CQ1 2025Apr 30, 2025$929.09K-11.2%
Q3 FY2025CQ4 2024Jan 31, 2025$1.03M+102.8%
Q2 FY2025CQ3 2024Oct 31, 2024$1.20M+58.3%
Q1 FY2025CQ2 2024Jul 31, 2024$1.22M+116.6%
Q4 FY2024CQ1 2024Apr 30, 2024$1.05M+95.7%
Q3 FY2024CQ4 2023Jan 31, 2024$509.51K-20.8%
Q2 FY2024CQ3 2023Oct 31, 2023$757.30K-10.8%
Q1 FY2024CQ2 2023Jul 31, 2023$565.63K+30.3%
Q4 FY2023CQ1 2023Apr 30, 2023$534.44K-60.6%
Q3 FY2023CQ4 2022Jan 31, 2023$643.26K-8.0%
Q2 FY2023CQ3 2022Oct 31, 2022$848.98K+55.6%
Q1 FY2023CQ2 2022Jul 31, 2022$434.20K+8.2%
Q4 FY2022CQ1 2022Apr 30, 2022$1.36M–
Q3 FY2022CQ4 2021Jan 31, 2022$699.02K–
Q2 FY2022CQ3 2021Oct 31, 2021$545.77K–
Q1 FY2022CQ2 2021Jul 31, 2021$401.11K–

More HeartSciences figures

See a number that looks wrong?